XNAzymes targeting the SARS-CoV-2 genome inhibit viral infection (2022)
Attributed to:
MRC Transition Support CSF Nicholas Matheson
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.90760
Publication URI: https://www.repository.cam.ac.uk/handle/1810/343348
Type: Journal Article/Review